BioCentury | Oct 17, 2020
Emerging Company Profile

Fed Bio: designing gut microbiomes with staying power and enhancing immune-modulating bacteria

...including Venrock and Altitude Ventures and new investor Seventure Partners...
BioCentury | Feb 6, 2020
Finance

Feb. 5 Financial Quick Takes: Aimmune gets $200M Nestlé investment; plus Vineti, MaaT, Kezar, Ziopharm, Ikarovec

...million ($19.9 million) in a series B from new investor SymBiosis LLC and existing investors Seventure Partners...
BioCentury | Sep 5, 2019
Financial News

Sept. 5 Financial Quick Takes: Zealand raises cash as it readies NDA; plus Bellus, Aerie, LNC, Veralox and Sigrid

...LNC Therapeutics (Bordeaux, France) raised €4.9 million ($5.4 million) in equity funding from existing investor Seventure Partners...
BioCentury | Jul 25, 2019
Emerging Company Profile

Axial: targeting gut microbe metabolites for CNS disorders

...Corporate partners: Taiho Ventures Number of employees: 21 Funds raised: $54 million Investors: Taiho Ventures, Seventure Partners...
BioCentury | Jul 17, 2019
Company News

July 17 Company Quick Takes: FDA approves Merck antibiotic combo; plus PureTech, Inovio, BiomX

...Its investors include OrbiMed Advisors, Johnson & Johnson Innovation - JJDC Inc., Takeda Ventures and Seventure Partners. Elizabeth...
BioCentury | Jun 3, 2019
Preclinical News

June 3 Preclinical Quick Takes: 'CRISPR baby' gene mutation increases mortality; Axial's microbiome for autism

...see "Seventure Leads Axial's $25M Series B" ). Mary Romeo, Staff Writer Axial Biotherapeutics Inc. California Institute of Technology Seventure Partners University...
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...$91.1 Series C Ysios Capital, OrbiMed Advisors, HBM Healthcare Investments, Bristol-Myers Squibb Co., Maverick Capital, Seventure Partners...
BioCentury | Mar 9, 2019
Finance

Seventure maps its microbiome future

...species and human disease. “For us, this represents a point of conversion.” Isabelle de Cremoux, Seventure Partners...
...considering going public this year; she did not disclose which. Mark Zipkin, Staff Writer Health for Life Capital Seventure Partners microbiome...
BioCentury | Mar 5, 2019
Financial News

First close for Seventure's new microbiome fund

...Siolta Therapeutics Inc. (San Francisco, Calif.); and DayTwo Ltd. (Israel). Mark Zipkin, Staff Writer Health for Life Capital Seventure Partners microbiome...
BioCentury | Mar 2, 2019
Company News

Emerging company roundup: Anthos, Maze, Oyster Point

...Anaveon” ). Axial Biotherapeutics Inc. (Boston, Mass.) raised a $25 million series B led by Seventure Partners...
Items per page:
1 - 10 of 72
BioCentury | Oct 17, 2020
Emerging Company Profile

Fed Bio: designing gut microbiomes with staying power and enhancing immune-modulating bacteria

...including Venrock and Altitude Ventures and new investor Seventure Partners...
BioCentury | Feb 6, 2020
Finance

Feb. 5 Financial Quick Takes: Aimmune gets $200M Nestlé investment; plus Vineti, MaaT, Kezar, Ziopharm, Ikarovec

...million ($19.9 million) in a series B from new investor SymBiosis LLC and existing investors Seventure Partners...
BioCentury | Sep 5, 2019
Financial News

Sept. 5 Financial Quick Takes: Zealand raises cash as it readies NDA; plus Bellus, Aerie, LNC, Veralox and Sigrid

...LNC Therapeutics (Bordeaux, France) raised €4.9 million ($5.4 million) in equity funding from existing investor Seventure Partners...
BioCentury | Jul 25, 2019
Emerging Company Profile

Axial: targeting gut microbe metabolites for CNS disorders

...Corporate partners: Taiho Ventures Number of employees: 21 Funds raised: $54 million Investors: Taiho Ventures, Seventure Partners...
BioCentury | Jul 17, 2019
Company News

July 17 Company Quick Takes: FDA approves Merck antibiotic combo; plus PureTech, Inovio, BiomX

...Its investors include OrbiMed Advisors, Johnson & Johnson Innovation - JJDC Inc., Takeda Ventures and Seventure Partners. Elizabeth...
BioCentury | Jun 3, 2019
Preclinical News

June 3 Preclinical Quick Takes: 'CRISPR baby' gene mutation increases mortality; Axial's microbiome for autism

...see "Seventure Leads Axial's $25M Series B" ). Mary Romeo, Staff Writer Axial Biotherapeutics Inc. California Institute of Technology Seventure Partners University...
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...$91.1 Series C Ysios Capital, OrbiMed Advisors, HBM Healthcare Investments, Bristol-Myers Squibb Co., Maverick Capital, Seventure Partners...
BioCentury | Mar 9, 2019
Finance

Seventure maps its microbiome future

...species and human disease. “For us, this represents a point of conversion.” Isabelle de Cremoux, Seventure Partners...
...considering going public this year; she did not disclose which. Mark Zipkin, Staff Writer Health for Life Capital Seventure Partners microbiome...
BioCentury | Mar 5, 2019
Financial News

First close for Seventure's new microbiome fund

...Siolta Therapeutics Inc. (San Francisco, Calif.); and DayTwo Ltd. (Israel). Mark Zipkin, Staff Writer Health for Life Capital Seventure Partners microbiome...
BioCentury | Mar 2, 2019
Company News

Emerging company roundup: Anthos, Maze, Oyster Point

...Anaveon” ). Axial Biotherapeutics Inc. (Boston, Mass.) raised a $25 million series B led by Seventure Partners...
Items per page:
1 - 10 of 72